Morgan Joseph Reiterates a 'Buy' on ImmunoGen (IMGN); Deal Brings Unprecedented Financial Stability
Tweet Send to a Friend
Morgan Joseph reiterates a 'Buy' on ImmunoGen, Inc. (Nasdaq: IMGN) and $12 price target.
Morgan analyst says, "On Monday, IMGN ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan analyst says, "On Monday, IMGN ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
